DK446986A - Arylsulfonamid-derivater med anti-tumor-virkning og fremgangsmaade til fremstilling af saadanne derivater - Google Patents

Arylsulfonamid-derivater med anti-tumor-virkning og fremgangsmaade til fremstilling af saadanne derivater Download PDF

Info

Publication number
DK446986A
DK446986A DK446986A DK446986A DK446986A DK 446986 A DK446986 A DK 446986A DK 446986 A DK446986 A DK 446986A DK 446986 A DK446986 A DK 446986A DK 446986 A DK446986 A DK 446986A
Authority
DK
Denmark
Prior art keywords
derivatives
preparing
procedure
tumor effect
aryl sulphonamide
Prior art date
Application number
DK446986A
Other languages
English (en)
Other versions
DK160981B (da
DK160981C (da
DK446986D0 (da
Inventor
James Jeffry Howbert
Gerald Auston Poore
Brent Jeffrey Rieder
Richard Waltz Harper
Eddie Vi-Ping Tao
James Abraham Aikins
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of DK446986D0 publication Critical patent/DK446986D0/da
Publication of DK446986A publication Critical patent/DK446986A/da
Publication of DK160981B publication Critical patent/DK160981B/da
Application granted granted Critical
Publication of DK160981C publication Critical patent/DK160981C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/54Benzoxazoles; Hydrogenated benzoxazoles
    • C07D263/56Benzoxazoles; Hydrogenated benzoxazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/08Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/62Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D319/00Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/101,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/141,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/161,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D319/18Ethylenedioxybenzenes, not substituted on the hetero ring

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Furan Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Indole Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK446986A 1985-09-23 1986-09-18 Arylsulfonylurinstof-derivater, fremgangsmaade til fremstilling deraf, anvendelse af disse som terapeutisk og antineoplastisk middel samt farmaceutiske midler indeholdende saadanne derivater DK160981C (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US77935485A 1985-09-23 1985-09-23
US77935485 1985-09-23
US88867586A 1986-07-24 1986-07-24
US88867586 1986-07-24

Publications (4)

Publication Number Publication Date
DK446986D0 DK446986D0 (da) 1986-09-18
DK446986A true DK446986A (da) 1987-03-24
DK160981B DK160981B (da) 1991-05-13
DK160981C DK160981C (da) 1991-10-28

Family

ID=27119572

Family Applications (1)

Application Number Title Priority Date Filing Date
DK446986A DK160981C (da) 1985-09-23 1986-09-18 Arylsulfonylurinstof-derivater, fremgangsmaade til fremstilling deraf, anvendelse af disse som terapeutisk og antineoplastisk middel samt farmaceutiske midler indeholdende saadanne derivater

Country Status (21)

Country Link
EP (1) EP0222475B1 (da)
JP (1) JPH0662548B2 (da)
KR (1) KR880000204B1 (da)
CN (1) CN1013198B (da)
AU (1) AU587064B2 (da)
CY (1) CY1659A (da)
DE (1) DE3667168D1 (da)
DK (1) DK160981C (da)
EG (1) EG18046A (da)
ES (1) ES2001698A6 (da)
GR (1) GR862353B (da)
HK (1) HK88692A (da)
HU (1) HU200597B (da)
IE (1) IE59588B1 (da)
IL (1) IL80032A (da)
MX (1) MX9203126A (da)
NZ (1) NZ217597A (da)
PT (1) PT83389B (da)
SG (1) SG66892G (da)
SU (1) SU1545939A3 (da)
UA (1) UA5953A1 (da)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4845128A (en) * 1984-06-27 1989-07-04 Eli Lilly And Company N([(4-trifluoromethylphenyl)amino]carbonyl)benzene sulfonamides
CA1331464C (en) * 1987-05-12 1994-08-16 Eli Lilly And Company Anti-tumor method and compounds
HU202487B (en) * 1988-03-04 1991-03-28 Mta Koezponti Kemiai Kutato In Process for producing n-sulfonylureas
ZA915371B (en) * 1990-07-17 1993-03-31 Lilly Co Eli Antitumor compositions and methods of treatment
US5216026A (en) * 1990-07-17 1993-06-01 Eli Lilly And Company Antitumor compositions and methods of treatment
US5262440A (en) * 1991-12-10 1993-11-16 Eli Lilly And Company Antitumor compositions and methods of treatment
US5258406A (en) * 1991-12-20 1993-11-02 Eli Lilly And Company Sulfonimidamides
US5234955A (en) * 1991-12-20 1993-08-10 Eli Lilly And Company Antitumor compositions and methods of treatment
US5254582A (en) * 1992-02-05 1993-10-19 Eli Lilly And Company Antitumor compositions and methods
US5169860A (en) * 1992-03-13 1992-12-08 Eli Lilly And Company Antitumor compositions and methods of treatment
US5270329A (en) * 1992-12-10 1993-12-14 Eli Lilly And Company Antitumor compositions and methods of treatment
CA2110524A1 (en) * 1992-12-10 1994-06-11 Gerald Burr Grindey Antitumor compositions and methods of treatment
ZA941500B (en) * 1993-03-10 1995-09-04 Lilly Co Eli Antitumor compositions and methods of treatment
US6063911A (en) * 1993-12-01 2000-05-16 Marine Polymer Technologies, Inc. Methods and compositions for treatment of cell proliferative disorders
CA2212405C (en) * 1996-08-07 2005-05-10 Takashi Suzuki Method for treating waste water
AU709107B2 (en) * 1996-08-22 1999-08-19 Dong Wha Pharmaceutical Industrial Co., Ltd. Arylsulfonylimidazolone derivatives as an antitumor agent
ES2156550B1 (es) * 1999-04-19 2002-02-01 Univ Navarra Publica Derivados de benzo(b) tiofenosulfonamida-1,1-dioxido y su uso como agentes antineoplasicos.
EP2364699A1 (en) 2004-09-13 2011-09-14 Eisai R&D Management Co., Ltd. Joint use of sulfonamide based compound with angiogenesis inhibitor
JP5134247B2 (ja) * 2004-09-13 2013-01-30 エーザイ・アール・アンド・ディー・マネジメント株式会社 スルホンアミド含有化合物の血管新生阻害物質との併用
US8772269B2 (en) 2004-09-13 2014-07-08 Eisai R&D Management Co., Ltd. Use of sulfonamide-including compounds in combination with angiogenesis inhibitors
WO2006090932A1 (ja) * 2005-02-28 2006-08-31 Eisai R & D Managemant Co., Ltd. スルホンアミド化合物の代理マーカー
KR20070114774A (ko) * 2005-02-28 2007-12-04 에자이 알앤드디 매니지먼트 가부시키가이샤 술폰아미드 화합물의 혈관 신생 저해 물질과의 신규 병용
SI1859793T1 (sl) * 2005-02-28 2011-08-31 Eisai R&D Man Co Ltd Nova kombinirana uporaba sulfonamidne spojine za zdravljenje raka
JPWO2007123274A1 (ja) 2006-04-20 2009-09-10 エーザイ・アール・アンド・ディー・マネジメント株式会社 スルホンアミド化合物の新規感受性マーカー
JP2012136435A (ja) * 2009-03-30 2012-07-19 Eisai R & D Management Co Ltd 腫瘍組織の感受性を検査する方法
CN102993106B (zh) * 2012-12-24 2015-06-17 武汉武药制药有限公司 格列吡嗪的合成新路线
GB201618240D0 (en) * 2016-10-27 2016-12-14 Trade Vehicle Locks Ltd Apparatus for locking a door of a vehicle

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1144259B (de) * 1956-05-29 1963-02-28 Hoechst Ag Verfahren zur Herstellung von Sulfonylharnstoffen
US3097242A (en) * 1960-06-29 1963-07-09 Olin Mathieson Hydrindene sulfonylureas
DE1159937B (de) * 1960-06-29 1963-12-27 Heyden Chem Fab Verfahren zur Herstellung von Hydrindensulfonylharnstoffen
DE1240866B (de) * 1961-06-29 1967-05-24 Heyden Chem Fab Verfahren zur Herstellung von Indolin-6-sulfonylharnstoffen
US4634465A (en) * 1982-07-16 1987-01-06 Ciba-Geigy Corporation Fused N-phenylsulfonyl-N'-pyrimidinylureas and N-phenylsulfonyl-N'triazinylureas
IT1161220B (it) * 1983-04-21 1987-03-18 Montedison Spa Diidro-benzofurano derivati ad attivita' erbicida
US4845128A (en) * 1984-06-27 1989-07-04 Eli Lilly And Company N([(4-trifluoromethylphenyl)amino]carbonyl)benzene sulfonamides

Also Published As

Publication number Publication date
IL80032A (en) 1992-07-15
DK160981B (da) 1991-05-13
KR880000204B1 (ko) 1988-03-12
ES2001698A6 (es) 1988-06-01
IE59588B1 (en) 1994-03-09
HUT46657A (en) 1988-11-28
SG66892G (en) 1992-09-04
EG18046A (en) 1991-08-30
CY1659A (en) 1993-05-14
CN86106428A (zh) 1987-03-18
DE3667168D1 (de) 1990-01-04
MX9203126A (es) 1992-07-01
GR862353B (en) 1987-01-19
HU200597B (en) 1990-07-28
SU1545939A3 (ru) 1990-02-23
PT83389B (pt) 1989-05-12
AU6294286A (en) 1987-03-26
DK160981C (da) 1991-10-28
AU587064B2 (en) 1989-08-03
CN1013198B (zh) 1991-07-17
EP0222475A1 (en) 1987-05-20
NZ217597A (en) 1989-06-28
UA5953A1 (uk) 1994-12-29
KR870003086A (ko) 1987-04-15
JPH0662548B2 (ja) 1994-08-17
IE862503L (en) 1987-03-23
PT83389A (en) 1986-10-01
HK88692A (en) 1992-11-20
DK446986D0 (da) 1986-09-18
JPS6296459A (ja) 1987-05-02
EP0222475B1 (en) 1989-11-29

Similar Documents

Publication Publication Date Title
DK446986A (da) Arylsulfonamid-derivater med anti-tumor-virkning og fremgangsmaade til fremstilling af saadanne derivater
DK491186A (da) Pyridonderivater og fremgangsmaade til fremstilling deraf
DK33287A (da) Imidazolanaloge af mevalonolacton og derivater deraf
NO860190L (no) Peptid-derivater og fremgangsmaate for fremstilling derav.
DK301886A (da) Furanon-derivater og fremgangsmaade til fremstilling heraf
DK165321C (da) Oxiranderivater og fremgangsmaade til fremstilling deraf
DK313086D0 (da) Phenoxyalkylisoxazol- eller -furanforbindelse og fremgangsmaade til fremstilling deraf
DK164486A (da) Molekylaert orienteret formstofnet og fremgangsmaade til fremstilling af dette
DK581688D0 (da) L-tyrosinderivater og fremgangsmaade til fremstilling af samme
DK165984C (da) Fremgangsmaade til fremstilling af sphingosinderivater
DK94686D0 (da) Nye oxadiazolylimidazobenzodiazepinderivater og fremgangsmaader til fremstilling af samme
DK133586A (da) Fremgangsmaade til fremstilling af chlorerede purinderivater
DK161086A (da) Nitrofuranderivater samt fremgangsmaade til fremstilling og anvendelse deraf
DK516286D0 (da) Fremgangsmaade til fremstilling af oxazolderivater
DK4187D0 (da) Triazolylquinolin-derivater og fremgangsmaade til fremstilling deraf
DK169386A (da) Fremgangsmaade til fremstilling af azetidinderivater og mellemprodukter dertil
DK343684D0 (da) Phenyletherderivater og fremgangsmaade til fremstilling deraf
DK445784A (da) Fluorenylalkylimidazol-derivater og fremgangsmaade til fremstilling deraf
DK343386A (da) Fremgangsmaade til fremstilling af 2-cyanamino-pyrimidin-derivater
DK318586A (da) Fremgangsmaade til fremstilling af acyloxybenzensulfonsyrer og saltederaf
DK120886A (da) Kredsloebsarrangement og fremgangsmaade til fremstilling af samme
DK165634C (da) Arylsulfonforbindelser og fremgangsmaader til fremstilling deraf
DK151640C (da) Fremgangsmaade til fremstilling af forbindelser med carcinostatisk og immunostimulerende virkning
DK443787A (da) Hydrazonderivater og fremgangsmaade til fremstilling deraf
DK50686D0 (da) Difficolforbindelse og fremgangsmaade til fremstilling deraf

Legal Events

Date Code Title Description
PBP Patent lapsed

Country of ref document: DK